ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 763

$1.72M Total Retail Price of All Prescriptions

Rank: 3 out of 763

665 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

7% of this provider’s 3,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$107 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
BENZTROPINE MESYLATE 936 185 R 1 4
RISPERIDONE 874 172 2 1
FLUOXETINE HCL 795 160 3 9
VENLAFAXINE HCL ER 744 70 10 4 8
TRAZODONE HCL 697 134 5 2
SERTRALINE HCL 651 138 6 5
QUETIAPINE FUMARATE 646 123 7 6
CITALOPRAM HBR 644 229 8 3
ABILIFY 644 80 8 7
OLANZAPINE 643 145 10 12
CLOZAPINE 548 54 11 10
HALOPERIDOL 453 96 12 24
LAMOTRIGINE 423 87 13 11
BUPROPION HCL SR 416 145 14 15
DIVALPROEX SODIUM 410 43 15 20
LITHIUM CARBONATE 404 34 16 17
MIRTAZAPINE 402 139 17 14
CYMBALTA 316 25 18 16
DIVALPROEX SODIUM ER 295 0 19 18
SEROQUEL 286 82 20 26
PAROXETINE HCL 271 37 21 21
PERPHENAZINE 254 26 22 31
SEROQUEL XR 205 16 23 28
THIOTHIXENE 204 47 10 24 57
DONEPEZIL HCL 199 148 25 35
ZOLPIDEM TARTRATE 196 32 26 13
GABAPENTIN 185 18 27 22
FLUPHENAZINE HCL 175 12 28 40
DOXEPIN HCL 162 62 29 34
BUSPIRONE HCL 160 33 30 19
CARBAMAZEPINE 120 21 31 32
BUPROPION XL 113 19 32 25
HALOPERIDOL DECANOATE 111 0 33 51
NAMENDA 108 74 34 38
TOPIRAMATE 107 0 35 30
ESCITALOPRAM OXALATE 106 22 36 23
FLUVOXAMINE MALEATE 105 0 37 42
AMPHETAMINE SALT COMBO 90 0 S2 38 33
ZIPRASIDONE HCL 90 0 38 27
CLOMIPRAMINE HCL 89 23 R 40 56
HYDROXYZINE PAMOATE 77 0 R 41 29
AMITRIPTYLINE HCL 73 30 R 42 41
VENLAFAXINE HCL 69 45 43 46
PROPRANOLOL HCL 64 22 44 48
CARBAMAZEPINE XR 62 0 45 62
CHLORPROMAZINE HCL 62 13 45 37
TRIFLUOPERAZINE HCL 60 13 47 64
TEGRETOL 56 15 48 131
AMANTADINE 56 12 48 77
FLUPHENAZINE DECANOATE 52 0 50 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.